0001567619-19-006728.txt : 20190312 0001567619-19-006728.hdr.sgml : 20190312 20190312175010 ACCESSION NUMBER: 0001567619-19-006728 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190308 FILED AS OF DATE: 20190312 DATE AS OF CHANGE: 20190312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hartman Thomas E CENTRAL INDEX KEY: 0001466989 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 19676221 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0306 4 2019-03-08 0 0000722723 HANGER, INC. HNGR 0001466989 Hartman Thomas E 10910 DOMAIN DRIVE SUITE 300 AUSTIN TX 78758 0 1 0 0 SVP and General Counsel Common Stock 2019-03-08 4 A 0 9134 0 A 63463 D Common Stock 2019-03-08 4 A 0 8868 0 A 72331 D Common Stock 2019-03-08 4 F 0 1915 19.30 D 70416 D Common Stock 2019-03-09 4 F 0 1870 19.30 D 68546 D Stock Options (right to buy) 12.77 2027-05-19 Common Stock 70818 70818 D Performance Share Units 2020-05-19 Common Stock 28327 28327 D Represents a grant of time-based restricted stock under the Company's 2016 Omnibus Incentive Plan ("Plan"), which vests to the extent of 25% annually beginning on the first anniversary date of the grant and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 9,134 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2019. Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2018 and ending on December 31, 2018. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date. Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued. Consists of (i) unvested restricted shares totaling 9,134 shares of stock from an initial grant of 9,134 shares of restricted stock that begins to vest on March 8, 2020; (ii) unvested restricted shares and fully vested shares totaling 8,039 shares of stock from an initial grant of 8,868 shares of restricted stock that begins to vest on March 9, 2019; (iii) unvested restricted shares and fully vested shares totaling 8,879 shares of stock from an initial grant of 10,500 shares of restricted stock, 25% of which vested on May 17, 2018 and the remainder of which will vest on March 8, 2019, 2020 and 2021; (iv) unvested restricted shares and fully vested shares totaling 10,106 shares of stock from an initial grant of 11,147 shares of restricted stock that begins to vest on March 9, 2019; [continued in next footnote] (v) unvested restricted shares and fully vested shares totaling 4,363 shares of stock from an initial grant of 6,359 shares of restricted stock, half of which vested on January 25, 2018 and the remainder of which will vest on March 6, 2018 and 2019; (vi) unvested restricted shares and fully vested shares totaling 8,457 shares of stock from an initial grant of 10,000 shares of restricted stock that begins to vest on March 8, 2018; (vii) unvested restricted shares and fully vested shares totaling 4,353 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (viii) unvested restricted shares and fully vested shares totaling 5,964 shares of stock from an initial grant of 10,000 shares of restricted stock that begins to vest on March 7, 2017; [continued in next footnote] (ix) unvested restricted shares and fully vested shares totaling 3,977 shares of stock from an initial grant of 4,958 shares of restricted stock made on November 10, 2015; (x) unvested restricted shares and fully vested shares totaling 2,432 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015; (xi) fully vested shares totaling 764 shares of stock from an initial grant of 1,731 shares of restricted stock made on March 7, 2014 (xii) fully vested shares totaling 878 shares of stock from an initial grant of 3,246 shares of restricted stock and performance made on March 11, 2013; and (xiii) fully vested shares totaling 1,200 shares from an initial grant of 4,800 shares of restricted stock made on March 7, 2012. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020. Performance share units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Thomas E. Hartman 2019-03-12